A detailed history of Hb Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hb Wealth Management, LLC holds 88,249 shares of ABBV stock, worth $15.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
88,249
Previous 93,239 5.35%
Holding current value
$15.3 Million
Previous $14.4 Million 11.22%
% of portfolio
0.2%
Previous 0.21%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $797,501 - $908,679
-4,990 Reduced 5.35%
88,249 $16.1 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $222,774 - $250,896
1,619 Added 1.77%
93,239 $14.4 Million
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $578,043 - $669,170
4,327 Added 4.96%
91,620 $13.7 Million
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $274,428 - $341,507
-2,071 Reduced 2.32%
87,293 $11.8 Million
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $381,915 - $439,832
2,641 Added 3.05%
89,364 $14.2 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $1.35 Million - $1.61 Million
9,731 Added 12.64%
86,723 $0
Q3 2022

Oct 19, 2022

BUY
$134.21 - $153.93 $1.81 Million - $2.08 Million
13,494 Added 21.25%
76,992 $10.3 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $2.53 Million - $3.21 Million
18,353 Added 40.65%
63,498 $9.73 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $675,605 - $838,236
5,119 Added 12.79%
45,145 $7.32 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $4.3 Million - $5.44 Million
40,026 New
40,026 $5.42 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.